Researchers have screened thousands of approved drugs against a network of 2,358 longevity-linked genes, producing a shortlist of compounds that may slow biological aging without new drug development.

The fund-raising values the company at $3.8 billion and underscores investor interest in using artificial intelligence to ...

A new AHA Market Scan Trailblazers report, sponsored by Concord Technologies, examines how AI — with its ability to quickly ...

Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.

What if the cure for your disease was already sitting on a drugstore shelf? That's the audacious premise driving Dr. David ...

Researchers cobbled together funding and time to show how quantum computing could aid in the development of drugs to help ...

The technology has arrived in the drug lab. But should investors pay up for it?

A feature News and Perspectives story on technological advances in oncology was published in Journal of Medical Internet ...

Google DeepMind’s Coscientist and Future House’s Robin use multi-agent AI systems to propose testable biomedical hypotheses ...

About one in five U.S. high school students seriously considered attempting suicide in the past year, and roughly 40 percent ...

Meta's new Muse Image AI lets Instagram users share and modify other people's public posts, sparking privacy concerns about ...

Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.